HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aveda Sheds Light On Mineral-Infused Makeup Line

This article was originally published in The Rose Sheet

Executive Summary

Aveda Inner Light makeup is a mineral-infused range of concealers, foundations and powders that boost skin's radiance almost 20%, according to the Estee Lauder division

You may also be interested in...



Aveda GDV Research Measures Raw Material Energies

Aveda researchers are using a new bioelectrography technique, gas discharge visualization, to measure the inherent energies in plant-based ingredients and "energy-embedded" raw materials to develop new cosmetic formulations

Aveda

Tourmaline Charged Hydrating Creme contains pine bark, grapeseed, green tea and astragalus to improve the luminous quality of the skin, Aveda claims. Mugwort and meadowfoam condition the skin, while plankton boosts moisture retention levels. Tourmaline, a naturally found gem, works to "increase the vibrational energy of the ingredients" to improve "nutritive properties," the Estee Lauder company claims. Available in January, a 1.7 oz. creme costs $30. Ads will break in February books, including Glamour, Mademoiselle, In Style and Self

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel